Impact of preprocedural TIMI flow on myocardial perfusion, distal embolization and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb/IIIa inhibitors

Journal of Invasive Cardiology

Volumn 24, Issue 7, 2012, Pages 324-327

  Maioli, Mauro ^a   Zeymer, Uwe ^b   Van 'T Hof, Arnoud W J ^c   Gibson, C Michael ^d   Dudek, Dariusz ^e   Bellandi, Francesco ^a   Noc, Marko ^f   Secco, Gioel Gabrio ^g   Zorman, Simona ^f   Gabriel, H Mesquita ^h   Emre, Ayse ⁱ   Cutlip, Donald ^j   Rakowski, Tomasz ^e   Gyongyosi, Maryann ^k   Huber, Kurt ^l   De Luca, Giuseppe ^m  

^a Prato Hospital   (Italy)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

^c HOSPITAL DE WEEZENLANDEN   (Netherlands)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^f UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^g UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^h HOSPITAL DE SANTA MARIA   (Portugal)

ⁱ DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^j BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^k MEDICAL UNIVERSITY OF VIENNA   (Austria)

^l WILHELMINEN HOSPITAL   (Austria)

^m MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

more..

Author keywords

mortality; perfusion; preprocedural recanalization; primary angioplasty

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; ANGIOPLASTY; ARTICLE; ARTIFICIAL EMBOLISM; FEMALE; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDES; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; REGIONAL BLOOD FLOW; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THROMBOSIS; TREATMENT OUTCOME; TYROSINE;

EID: 84864326979     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomized trials. Lancet. 2003;361(9351):13-20. (Pubitemid 36050955)
2. De Luca G, van t Hof AW, Ottervanger JP, et al. Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Am Heart J. 2005;150(3):557-562. (Pubitemid 41317629)
3. Sakuma T, Leong-Poi H, Fisher NG, Goodman NC, Kaul S. Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: The role of microthromboemboli. J Am Soc Echocardiogr. 2003;16(1):15-21. (Pubitemid 36522812)
4. De Luca G, Suryapranata H, Chiariello M. Prevention of distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction. A review of cur rent status. Thromb Haemost. 2006;96(6):700-710. (Pubitemid 44883808)
5. De Luca G, van t Hof AW, de Boer MJ, et al. Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty. Eur Heart J. 2004;25(12):1009-1013. (Pubitemid 38869418)
6. De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: Every minute of delay counts. Circulation. 2004;109(10):1223-1225. (Pubitemid 38372780)
7. Tarantini G, Cacciavillani L, Corbetti F, et al. Duration of ischemia is a major deter minant of transmurality and severe microvascular obstruction after primary angioplas ty: A study performed with contrast-enhanced magnetic resonance. J Am Coll Cardiol. 2005;46(7):1229-1235. (Pubitemid 41615542)
8. De Luca G, Gibson CM, Bellandi F, et al. Early glycoprotein IIb-IIIa inhibitors in pri mary angioplasty (EGYPT) cooperation. An individual patient data meta-analysis. Heart. 2008;94(12):1548-1558.
9. De Luca G, Biondi-Zoccai G, Marino P. Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: A meta-regression analysis of random ized trials. Ann Emerg Med. 2008;52(6):665-676.
10. Stone GW, Cox D, Garcia E, et al. Normal flow (TIMI-3) before mechanical reperfu sion therapy is an independent determinant of survival in acute myocardial infarc tion: Analysis from the primary angioplasty in myocardial infarction trials. Circulation. 2001;104(6):636-641. (Pubitemid 32738515)
11. Brodie BR, Stuckey TD, Hansen C, Muncy D. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol. 2000;85(1):13-18. (Pubitemid 30045537)
12. Flameng W, Lesaffre E, Vanhaecke J. Determinants of infarct size in non-human primates. Bas Res Cardiol. 1990;85(4):392-403. (Pubitemid 20275673)
13. Reimer KA, Vander Heide RS, Richard VJ. Reperfusion in acute myocardial infarc tion: Effects of timing and modulating factors in experimental models. Am J Cardiol. 1993;72(19):13G-21G. (Pubitemid 24023481)
14. Garcia-Dorado D, Theroux P, Elizaga J, et al Myocardial infarction in the pig heart model: Infarct size and duration of coronary occlusion. Cardiovasc Res. 1987;21(7):537-544. (Pubitemid 17106456)
15. Herrmann HC, Lu J, Brodie BR, et al; FINESSE Investigators. Benefit of facilitated per cutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to non-percutaneous coronary intervention hospitals. JACC Cardiovasc Interv. 2009;2(10):917-924.
16. Dudek D, Siudak Z, Janzon M, et al; EUROTRANSFER Registry Investigators. Europe an registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab - EUROTRANS FER registry. Am Heart J. 2008;156(6):1147-1154.
17. Ortolani P, Marzocchi A, Marrozzini C, et al. Long-term effectiveness of early administra tion of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percuta neous interventions: Results of a registry study in an ST-elevation myocardial infarction network. Eur Heart J. 2009;30(1):33-43.
18. Galiuto L, Lombardo A, Maseri A, et al. Temporal evolution and functional outcome of no reflow: Sustained and spontaneously reversible patterns following successful coronary recanalisation. Heart. 2003;89(7):731-737. (Pubitemid 36760629)
19. Hoffmann R, Haager P, Arning J, et al. Usefulness of myocardial blush grade early and late after primary coronary angioplasty for acute myocardial infarction in predicting left ventricular function. Am J Cardiol. 2003;92(9):1015-1019. (Pubitemid 37329523)